Karen A. Dawes - 27 Feb 2024 Form 4 Insider Report for REPLIGEN CORP (RGEN)

Role
Director
Signature
/s/ Kimberly Brown (Attorney in Fact)
Issuer symbol
RGEN
Transactions as of
27 Feb 2024
Net transactions value
+$1,266
Form type
4
Filing time
28 Feb 2024, 21:56:23 UTC
Previous filing
30 Aug 2023
Next filing
14 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RGEN Common Stock Options Exercise $194,616 +4,626 +5.5% $42.07 88,367 27 Feb 2024 Direct
transaction RGEN Common Stock Sale $193,350 -1,000 -1.1% $193.35 87,367 27 Feb 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RGEN Stock Option (Right to Buy) Options Exercise $0 +4,626 $0.000000* 0 27 Feb 2024 Common Stock 4,626 $42.07 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option is fully vested and exercisable.